NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.909
+0.007 (0.79%)
At close: Feb 27, 2026, 4:00 PM EST
0.920
+0.011 (1.22%)
After-hours: Feb 27, 2026, 7:58 PM EST
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $30.35 million as of February 27, 2026. Its market cap has increased by 12.93% in one year.
Market Cap
30.35M
Enterprise Value
29.69M
1-Year Change
12.93%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $30.35M, a decrease of -53.02%. That is a compound annual growth rate of -16.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 30.35M | 32.91% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 31.88M |
| Rein Therapeutics | 31.68M |
| Tempest Therapeutics | 30.33M |
| AN2 Therapeutics | 29.32M |
| ABVC BioPharma | 29.14M |
| BriaCell Therapeutics | 28.83M |
| Werewolf Therapeutics | 28.72M |
| Kyntra Bio | 28.56M |